Company Information

1. Name

MEDIPOST Co., Ltd.

2. Website Address

http://www.medi-post.com

3. Location

21, Daewangpangyo-ro 644, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea

4. Contacts

http://www.medi-post.com/stem-cell-therapy-qna/

5. References

Pharmaceutical Product Information

1. Brand Name

CARTISTEM®

2. Active Ingredient

Human Umbilical Cord Blood-derived Mesenchymal Stem Cells, 7.5x106 cells/vial

3. Indication

For the treatment of knee articular cartilage defects in patients with osteoarthritis (ICRS grade IV) as a result of degenerative disease or repeated trauma

4. Information

CARTISTEM®is a drug based on allogeneic umbilical cord blood derived mesenchymal stem cells. It is indicated to treat knee cartilage defects as a result of degenerative osteoarthritis or repeated trauma. CARTISTEM® is administered to through either a surgical method or an arthroscope.

Approved by MFDS Korea in January, 2012

5. Images